Preparing for Growth in Neurodegenerative Treatment Opportunities

Preparing for growth in neurodegenerative treatment opportunities

While patient enrollment and retention for clinical trials in this field can be challenging, CROs with the right expertise, tools and passion can help sponsors implement successful, cost-effective studies that minimize site and patient burden. This article covers:

• Current clinical research in neuroscience
• Complexity and challenges
• Protocol optimization
• Supported neurodegenerative disease clinical trials

Input from Alberto Lledó, M.D., Ph.D., Christine Martino, John Hamlet, and Sabine Krofczik-Wilhelm, Ph.D., PPD clinical research business of Thermo Fisher Scientific